Impact of microablative fractional radiofrequency on the vaginal health, microbiota, and cellularity of postmenopausal women
暂无分享,去创建一个
A. Gonçalves | P. Giraldo | C. Marconi | A. Sarmento | J. C. Crispim | F. S. Fernandes | J. Eleuterio-Junior
[1] S. Wozniak,et al. Genitourinary syndrome of menopause treatment using lasers and temperature-controlled radiofrequency , 2018, Przeglad menopauzalny = Menopause review.
[2] F. Riva,et al. Early Regenerative Modifications of Human Postmenopausal Atrophic Vaginal Mucosa Following Fractional CO2 Laser Treatment , 2018, Open access Macedonian journal of medical sciences.
[3] Márcia Farina Kamilos,et al. New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency , 2017, Einstein.
[4] Robert D Moore,et al. Transcutaneous Temperature Controlled Radiofrequency ( TTCRF ) for the Treatment of Menopausal Vaginal / Genitourinary Symptoms-1-# 772 , 2022 .
[5] M. Karram,et al. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy , 2016, Menopause.
[6] M. Falagas,et al. The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women , 2016, Climacteric : the journal of the International Menopause Society.
[7] F. Vicariotto,et al. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device. , 2016, Minerva ginecologica.
[8] S. Caruso,et al. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel , 2016, Menopause.
[9] N. Biglia,et al. Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Are We Facing New and Safe Hopes? , 2015, Clinical breast cancer.
[10] D. Portman,et al. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society , 2014, Climacteric : the journal of the International Menopause Society.
[11] S. Ferrero,et al. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study , 2014, Climacteric : the journal of the International Menopause Society.
[12] F. Marotta,et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment , 2014, Lasers in Medical Science.
[13] M. Martens,et al. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society , 2013, Menopause.
[14] S. Kingsberg,et al. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. , 2013, The journal of sexual medicine.
[15] U. Jaisamrarn,et al. Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy , 2013, Climacteric : the journal of the International Menopause Society.
[16] A. Cano,et al. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study , 2012, Menopause.
[17] S. Davis. Understanding female sexual function. , 2009, Menopause.
[18] C. Labrie,et al. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women , 2009, Menopause.
[19] X. Albert,et al. Oestrogens for Preventing Recurrent Urinary Tract Infection in Postmenopausal Women , 2008, Obstetrics and gynecology.
[20] G. Bachmann,et al. Diagnosis and treatment of atrophic vaginitis. , 2000, American family physician.
[21] K. Holmes,et al. Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid , 1983, Journal of clinical microbiology.